Diazoxide (Hyperstat) Nitroprusside sodium (Nipride)
  • Vasodilators used for acute management of hypertensive crisis or malignant hypertension include sodium nitroprusside and diazoxide.
  • Nitroprusside sodium (Nipride) is the agent of choice.
    • Administered by a continuously variable rate i.v. infusion pump, precise blood pressure control can be obtained.
    • Nitroprusside sodium (Nipride), a nitrovasodilator, is metabolized by smooth muscle cells to nitric oxide which dilates both arterioles and venules.
  •  Side effects are mainly due to excessive vasodilation.
    • Much less commonly, toxicity may result from conversion of nitroprusside to cyanide and thiocyanate.
    • Risk of toxicity due to thiocyanate increases after 24 to 48 hours.
    • Nitroprusside sodium (Nipride) can worsen arterial hypoxemia in patients with obstructive pulmonary airway disease since nitroprusside will interfere with hypoxic pulmonary vasoconstriction. A result is increasing ventilation-perfusion mismatching.
  • Diazoxide (Hyperstat) is infrequently used unless accurate infusion pumps are unavailable.
    • The mechanism of action involves activation of ATP-sensitive potassium channels, hyperpolarization of arteriolar smooth muscle, relaxation and dilation.
    • Adverse effects include salt and water retention and hyperglycemia. Diazoxide inhibits insulin release.